PU.1 is required for transcriptional activation of the Stat6 response element in the lgE promoter

European Journal of Immunology

Volumn 33, Issue 6, 2003, Pages 1727-1735

  Pesu, Marko ^a,b   Aittomäki, Saara ^a   Välineva, Tuuli ^a   Silvennoinen, Olli ^a,b  

^a UNIVERSITY OF TAMPERE   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

IL 4; lgE; PU.1; Stat6; Transcription

Indexed keywords

CIS ACTING ELEMENT; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 4; STAT6 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PU 1;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; BINDING SITE; BONE MARROW CELL; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; DNA BINDING; DNA RESPONSIVE ELEMENT; GENE EXPRESSION; GENE SEQUENCE; GENETIC REGULATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOMODULATION; IMMUNOSTIMULATION; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

BINDING SITES; BURKITT LYMPHOMA; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION; GENES, IMMUNOGLOBULIN; GENES, REPORTER; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-4; LIVER NEOPLASMS; POINT MUTATION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0038082239     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323680     Document Type: Article

References (31)

1. Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J. and Paul, W. E., The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 1999. 17: 701-738.
2. Kotanides, H. and Reich, N. C., Interleukin-4-induced STAT6 recognizes and activates a target site in the promoter of the interleukin-4 receptor gene. J. Biol. Chem. 1996. 271: 25555-25561.
3. Warren, W. D. and Berton, M. T., Induction of germ-line gamma 1 and epsilon Ig gene expression in murine B cells. IL-4 and the CD40 ligand-CD40 interaction provide distinct but synergistic signals. J. Immunol. 1995. 155: 5637-5646.
4. Kuhn, R., Rajewsky, K. and Muller, W., Generation and analysis of interleukin-4 deficient mice. Science 1991. 254: 707-710.
5. Shimoda, K., van Deursen, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., Chu, C., Quelle, F. W., Nosaka, T., Vignali, D. A., Doherty, P. C., Grosveld, G., Paul, W. E. and Ihle, J. N., Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996. 380: 630-633.
6. Richards, M. L. and Katz, D. H., Analysis of the promoter elements necessary for IL-4 and anti-CD40 antibody induction of murine Fc epsilon RII (CD23): comparison with the germline epsilon promoter. J. Immunol. 1997. 158: 263-272.
7. Gupta, S., Jiang, M., Anthony, A. and Pernis, A. B., Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. J. Exp. Med. 1999. 190: 1837-1848.
8. Shen, C. H. and Stavnezer, J., Interaction of stat6 and NF-kappa B: direct association and synergistic activation of interleukin-4-induced transcription. Mol. Cell. Biol. 1998. 18: 3395-3404.
9. Stutz, A. M. and Woisetschlager, M., Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription. J. Immunol. 1999. 163: 4383-4391.
10. Mikita, T., Kurama, M. and Schindler, U., Synergistic activation of the germline epsilon promoter mediated by Stat6 and C/EBP beta. J. Immunol. 1998. 161: 1822-1828.
11. Oettgen, H. C., Regulation of the IgE isotype switch: new insights on cytokine signals and the functions of epsilon germline transcripts. Curr. Opin. Immunol. 2000. 12: 618-623.
12. Thienes, C. P., De Monte, L., Monticelli, S., Busslinger, M., Gould, H. J. and Vercelli, D., The transcription factor B cell-specific activator protein (BSAP) enhances both IL-4- and CD40-mediated activation of the human epsilon germline promoter. J. Immunol. 1997. 158: 5874-5882.
13. Pesu, M., Aittomäki, S., Takaluoma, K., Lagerstedt, A. and Silvennoinen, O., p38 mitogen-activated protein kinase regulates interleukin-4-induced gene expression by stimulating STAT6-mediated transcription. J. Biol. Chem. 2002. 277: 38254-38261.
14. Himmelmann, A., Riva, A., Wilson, G. L., Lucas, B. P., Thevenin, C. and Kehrl, J. H., PU.1/Pip and basic helix loop helix zipper transcription factors interact with binding sites in the CD20 promoter to help confer lineage- and stage-specific expression of CD20 in B lymphocytes. Blood 1997. 90: 3984-3995.
15. Simon, M. C., PU.1 and hematopoiesis: lessons learned from gene targeting experiments. Semin. Immunol. 1998. 10: 111-118.
16. Lloberas, J., Soler, C. and Celada, A., The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages. Immunol. Today 1999. 20: 184-189.
17. Pongubala, J. M., Van Beveren, C., Nagulapalli, S., Klemsz, M. J., McKercher, S. R., Maki, R. A. and Atchison, M. L., Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science 1993. 259: 1622-1625.
18. Marecki, S., Riendeau, C. J., Liang, M. D. and Fenton, M. J., PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene. J. Immunol. 2001. 166: 6829-6838.
19. Meraro, D., Gleit-Kielmanowicz, M., Hauser, H. and Levi, B. Z., IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: characterization of a new subtype of IFN-stimulated response element. J. Immunol. 2002. 168: 6224-6231.
20. Moriggl, R., Berchtold, S., Friedrich, K., Standke, G. J., Kammer, W., Heim, M., Wissler, M., Stocklin, E., Gouilleux, F. and Groner, B., Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells. Mol. Cell. Biol. 1997. 17: 3663-3678.
21. Nikolajczyk, B. S., Sanchez, J. A. and Sen, R., ETS protein-dependent accessibility changes at the immunoglobulin mu heavy chain enhancer. Immunity 1999. 11: 11-20.
22. Fisher, R. C., Olson, M. C., Pongubala, J. M., Perkel, J. M., Atchison, M. L., Scott, E. W. and Simon, M. C., Normal myeloid development requires both the glutamine-rich transactivation domain and the PEST region of transcription factor PU.1 but not the potent acidic transactivation domain. Mol. Cell. Biol. 1998. 18: 4347-4357.
23. Lodie, T. A., Savedra, R. Jr., Golenbock, D. T., Van Beveren, C. P., Maki, R. A. and Fenton, M. J., Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. J. Immunol. 1997. 158: 1848-1856.
24. Chen, X., Vinkemeier, U., Zhao, Y., Jeruzalmi, D., Darnell, J. E. Jr. and Kuriyan, J., Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 1998. 93: 827-839.
25. Becker, S., Groner, B. and Muller, C. W., Three-dimensional structure of the Stat3 beta homodimer bound to DNA. Nature 1998. 394: 145-151.
26. Seidel, H. M., Milocco, L. H., Lamb, P., Darnell, J. E. Jr., Stein, R. B. and Rosen, J., Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc. Natl. Acad. Sci. U S A 1995. 92: 3041-3045.
27. Kodandapani, R., Pio, F., Ni, C. Z., Piccialli, G., Klemsz, M., McKercher, S., Maki, R. A. and Ely, K. R., A new pattern for helix-turn-helix recognition revealed by the PU.1 ETS-domain-DNA complex. Nature 1996. 380: 456-460.
28. Bluyssen, A. R., Durbin, J. E. and Levy, D. E., ISGF3 gamma p48, a specificity switch for interferon activated transcription factors. Cytokine Growth Factor Rev. 1996. 7: 11-17.
29. Saharinen, P., Ekman, N., Sarvas, K., Parker, P., Alitalo, K. and Silvennoinen, O., The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase C delta. Blood 1997. 90: 4341-4353.
30. Pesu, M., Takaluoma, K., Aittomäki, S., Lagerstedt, A., Saksela, K., Kovanen, P. E. and Silvennoinen, O., Interleukin-4-induced transcriptional activation by stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of stat6. Blood 2000. 95: 494-502.
31. Tanaka, M., Gupta, R. and Mayer, B. J., Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins. Mol. Cell. Biol. 1995. 15: 6829-6837.